Why Is Archer Aviation Stock Going Up?
Archer Aviation (NYSE:ACHR) is an aviation startup that is working…
Sell
41
UPV Quote, Financials, Valuation and Earnings
Last price:
$79.05
Seasonality move
:
-1.81%
Day range:
$78.40 - $79.05
52-week range:
$51.37 - $81.95
Dividend yield:
1.8%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
319
Avg. volume:
1.4K
1-year change:
21.54%
Market cap:
--
Revenue:
--
EPS (TTM):
--
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
UPV
ProShares Ultra FTSE Europe
|
-- | -- | -- | -- | -- |
|
EZJ
ProShares Ultra MSCI Japan
|
-- | -- | -- | -- | -- |
|
PILL
Direxion Daily Pharmaceutical & Medical Bl 3X Shs
|
-- | -- | -- | -- | -- |
|
UBR
ProShares Ultra MSCI Brazil Capped
|
-- | -- | -- | -- | -- |
|
UGE
ProShares Ultra Consumer Staples
|
-- | -- | -- | -- | -- |
|
XPP
ProShares Ultra FTSE China 50
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
UPV
ProShares Ultra FTSE Europe
|
$78.40 | -- | -- | -- | $0.34 | 1.8% | -- |
|
EZJ
ProShares Ultra MSCI Japan
|
$39.97 | -- | -- | -- | $0.18 | 1.74% | -- |
|
PILL
Direxion Daily Pharmaceutical & Medical Bl 3X Shs
|
$5.73 | -- | -- | -- | $0.02 | 1.48% | -- |
|
UBR
ProShares Ultra MSCI Brazil Capped
|
$18.71 | -- | -- | -- | $0.16 | 5.17% | -- |
|
UGE
ProShares Ultra Consumer Staples
|
$18.44 | -- | -- | -- | $0.12 | 1.89% | -- |
|
XPP
ProShares Ultra FTSE China 50
|
$26.69 | -- | -- | -- | $0.16 | 2.76% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
UPV
ProShares Ultra FTSE Europe
|
-- | 0.632 | -- | -- |
|
EZJ
ProShares Ultra MSCI Japan
|
-- | 0.696 | -- | -- |
|
PILL
Direxion Daily Pharmaceutical & Medical Bl 3X Shs
|
-- | 0.921 | -- | -- |
|
UBR
ProShares Ultra MSCI Brazil Capped
|
-- | 0.270 | -- | -- |
|
UGE
ProShares Ultra Consumer Staples
|
-- | 0.634 | -- | -- |
|
XPP
ProShares Ultra FTSE China 50
|
-- | 0.349 | -- | -- |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
UPV
ProShares Ultra FTSE Europe
|
-- | -- | -- | -- | -- | -- |
|
EZJ
ProShares Ultra MSCI Japan
|
-- | -- | -- | -- | -- | -- |
|
PILL
Direxion Daily Pharmaceutical & Medical Bl 3X Shs
|
-- | -- | -- | -- | -- | -- |
|
UBR
ProShares Ultra MSCI Brazil Capped
|
-- | -- | -- | -- | -- | -- |
|
UGE
ProShares Ultra Consumer Staples
|
-- | -- | -- | -- | -- | -- |
|
XPP
ProShares Ultra FTSE China 50
|
-- | -- | -- | -- | -- | -- |
ProShares Ultra FTSE Europe vs. Competitors
-
Which has Higher Returns UPV or EZJ?
ProShares Ultra MSCI Japan has a net margin of -- compared to ProShares Ultra FTSE Europe's net margin of --. ProShares Ultra FTSE Europe's return on equity of -- beat ProShares Ultra MSCI Japan's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital UPVProShares Ultra FTSE Europe-- -- -- EZJProShares Ultra MSCI Japan-- -- -- -
What do Analysts Say About UPV or EZJ?
ProShares Ultra FTSE Europe has a consensus price target of --, signalling downside risk potential of --. On the other hand ProShares Ultra MSCI Japan has an analysts' consensus of -- which suggests that it could fall by --. Given that ProShares Ultra FTSE Europe has higher upside potential than ProShares Ultra MSCI Japan, analysts believe ProShares Ultra FTSE Europe is more attractive than ProShares Ultra MSCI Japan.
Company Buy Ratings Hold Ratings Sell Ratings UPVProShares Ultra FTSE Europe0 0 0 EZJProShares Ultra MSCI Japan0 0 0 -
Is UPV or EZJ More Risky?
ProShares Ultra FTSE Europe has a beta of 1.865, which suggesting that the stock is 86.534% more volatile than S&P 500. In comparison ProShares Ultra MSCI Japan has a beta of 1.322, suggesting its more volatile than the S&P 500 by 32.248%.
-
Which is a Better Dividend Stock UPV or EZJ?
ProShares Ultra FTSE Europe has a quarterly dividend of $0.34 per share corresponding to a yield of 1.8%. ProShares Ultra MSCI Japan offers a yield of 1.74% to investors and pays a quarterly dividend of $0.18 per share. ProShares Ultra FTSE Europe pays -- of its earnings as a dividend. ProShares Ultra MSCI Japan pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios UPV or EZJ?
ProShares Ultra FTSE Europe quarterly revenues are --, which are smaller than ProShares Ultra MSCI Japan quarterly revenues of --. ProShares Ultra FTSE Europe's net income of -- is lower than ProShares Ultra MSCI Japan's net income of --. Notably, ProShares Ultra FTSE Europe's price-to-earnings ratio is -- while ProShares Ultra MSCI Japan's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for ProShares Ultra FTSE Europe is -- versus -- for ProShares Ultra MSCI Japan. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income UPVProShares Ultra FTSE Europe-- -- -- -- EZJProShares Ultra MSCI Japan-- -- -- --
-
Which has Higher Returns UPV or PILL?
Direxion Daily Pharmaceutical & Medical Bl 3X Shs has a net margin of -- compared to ProShares Ultra FTSE Europe's net margin of --. ProShares Ultra FTSE Europe's return on equity of -- beat Direxion Daily Pharmaceutical & Medical Bl 3X Shs's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital UPVProShares Ultra FTSE Europe-- -- -- PILLDirexion Daily Pharmaceutical & Medical Bl 3X Shs-- -- -- -
What do Analysts Say About UPV or PILL?
ProShares Ultra FTSE Europe has a consensus price target of --, signalling downside risk potential of --. On the other hand Direxion Daily Pharmaceutical & Medical Bl 3X Shs has an analysts' consensus of -- which suggests that it could fall by --. Given that ProShares Ultra FTSE Europe has higher upside potential than Direxion Daily Pharmaceutical & Medical Bl 3X Shs, analysts believe ProShares Ultra FTSE Europe is more attractive than Direxion Daily Pharmaceutical & Medical Bl 3X Shs.
Company Buy Ratings Hold Ratings Sell Ratings UPVProShares Ultra FTSE Europe0 0 0 PILLDirexion Daily Pharmaceutical & Medical Bl 3X Shs0 0 0 -
Is UPV or PILL More Risky?
ProShares Ultra FTSE Europe has a beta of 1.865, which suggesting that the stock is 86.534% more volatile than S&P 500. In comparison Direxion Daily Pharmaceutical & Medical Bl 3X Shs has a beta of 1.717, suggesting its more volatile than the S&P 500 by 71.662%.
-
Which is a Better Dividend Stock UPV or PILL?
ProShares Ultra FTSE Europe has a quarterly dividend of $0.34 per share corresponding to a yield of 1.8%. Direxion Daily Pharmaceutical & Medical Bl 3X Shs offers a yield of 1.48% to investors and pays a quarterly dividend of $0.02 per share. ProShares Ultra FTSE Europe pays -- of its earnings as a dividend. Direxion Daily Pharmaceutical & Medical Bl 3X Shs pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios UPV or PILL?
ProShares Ultra FTSE Europe quarterly revenues are --, which are smaller than Direxion Daily Pharmaceutical & Medical Bl 3X Shs quarterly revenues of --. ProShares Ultra FTSE Europe's net income of -- is lower than Direxion Daily Pharmaceutical & Medical Bl 3X Shs's net income of --. Notably, ProShares Ultra FTSE Europe's price-to-earnings ratio is -- while Direxion Daily Pharmaceutical & Medical Bl 3X Shs's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for ProShares Ultra FTSE Europe is -- versus -- for Direxion Daily Pharmaceutical & Medical Bl 3X Shs. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income UPVProShares Ultra FTSE Europe-- -- -- -- PILLDirexion Daily Pharmaceutical & Medical Bl 3X Shs-- -- -- --
-
Which has Higher Returns UPV or UBR?
ProShares Ultra MSCI Brazil Capped has a net margin of -- compared to ProShares Ultra FTSE Europe's net margin of --. ProShares Ultra FTSE Europe's return on equity of -- beat ProShares Ultra MSCI Brazil Capped's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital UPVProShares Ultra FTSE Europe-- -- -- UBRProShares Ultra MSCI Brazil Capped-- -- -- -
What do Analysts Say About UPV or UBR?
ProShares Ultra FTSE Europe has a consensus price target of --, signalling downside risk potential of --. On the other hand ProShares Ultra MSCI Brazil Capped has an analysts' consensus of -- which suggests that it could fall by --. Given that ProShares Ultra FTSE Europe has higher upside potential than ProShares Ultra MSCI Brazil Capped, analysts believe ProShares Ultra FTSE Europe is more attractive than ProShares Ultra MSCI Brazil Capped.
Company Buy Ratings Hold Ratings Sell Ratings UPVProShares Ultra FTSE Europe0 0 0 UBRProShares Ultra MSCI Brazil Capped0 0 0 -
Is UPV or UBR More Risky?
ProShares Ultra FTSE Europe has a beta of 1.865, which suggesting that the stock is 86.534% more volatile than S&P 500. In comparison ProShares Ultra MSCI Brazil Capped has a beta of 1.704, suggesting its more volatile than the S&P 500 by 70.366%.
-
Which is a Better Dividend Stock UPV or UBR?
ProShares Ultra FTSE Europe has a quarterly dividend of $0.34 per share corresponding to a yield of 1.8%. ProShares Ultra MSCI Brazil Capped offers a yield of 5.17% to investors and pays a quarterly dividend of $0.16 per share. ProShares Ultra FTSE Europe pays -- of its earnings as a dividend. ProShares Ultra MSCI Brazil Capped pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios UPV or UBR?
ProShares Ultra FTSE Europe quarterly revenues are --, which are smaller than ProShares Ultra MSCI Brazil Capped quarterly revenues of --. ProShares Ultra FTSE Europe's net income of -- is lower than ProShares Ultra MSCI Brazil Capped's net income of --. Notably, ProShares Ultra FTSE Europe's price-to-earnings ratio is -- while ProShares Ultra MSCI Brazil Capped's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for ProShares Ultra FTSE Europe is -- versus -- for ProShares Ultra MSCI Brazil Capped. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income UPVProShares Ultra FTSE Europe-- -- -- -- UBRProShares Ultra MSCI Brazil Capped-- -- -- --
-
Which has Higher Returns UPV or UGE?
ProShares Ultra Consumer Staples has a net margin of -- compared to ProShares Ultra FTSE Europe's net margin of --. ProShares Ultra FTSE Europe's return on equity of -- beat ProShares Ultra Consumer Staples's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital UPVProShares Ultra FTSE Europe-- -- -- UGEProShares Ultra Consumer Staples-- -- -- -
What do Analysts Say About UPV or UGE?
ProShares Ultra FTSE Europe has a consensus price target of --, signalling downside risk potential of --. On the other hand ProShares Ultra Consumer Staples has an analysts' consensus of -- which suggests that it could fall by --. Given that ProShares Ultra FTSE Europe has higher upside potential than ProShares Ultra Consumer Staples, analysts believe ProShares Ultra FTSE Europe is more attractive than ProShares Ultra Consumer Staples.
Company Buy Ratings Hold Ratings Sell Ratings UPVProShares Ultra FTSE Europe0 0 0 UGEProShares Ultra Consumer Staples0 0 0 -
Is UPV or UGE More Risky?
ProShares Ultra FTSE Europe has a beta of 1.865, which suggesting that the stock is 86.534% more volatile than S&P 500. In comparison ProShares Ultra Consumer Staples has a beta of 1.658, suggesting its more volatile than the S&P 500 by 65.8%.
-
Which is a Better Dividend Stock UPV or UGE?
ProShares Ultra FTSE Europe has a quarterly dividend of $0.34 per share corresponding to a yield of 1.8%. ProShares Ultra Consumer Staples offers a yield of 1.89% to investors and pays a quarterly dividend of $0.12 per share. ProShares Ultra FTSE Europe pays -- of its earnings as a dividend. ProShares Ultra Consumer Staples pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios UPV or UGE?
ProShares Ultra FTSE Europe quarterly revenues are --, which are smaller than ProShares Ultra Consumer Staples quarterly revenues of --. ProShares Ultra FTSE Europe's net income of -- is lower than ProShares Ultra Consumer Staples's net income of --. Notably, ProShares Ultra FTSE Europe's price-to-earnings ratio is -- while ProShares Ultra Consumer Staples's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for ProShares Ultra FTSE Europe is -- versus -- for ProShares Ultra Consumer Staples. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income UPVProShares Ultra FTSE Europe-- -- -- -- UGEProShares Ultra Consumer Staples-- -- -- --
-
Which has Higher Returns UPV or XPP?
ProShares Ultra FTSE China 50 has a net margin of -- compared to ProShares Ultra FTSE Europe's net margin of --. ProShares Ultra FTSE Europe's return on equity of -- beat ProShares Ultra FTSE China 50's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital UPVProShares Ultra FTSE Europe-- -- -- XPPProShares Ultra FTSE China 50-- -- -- -
What do Analysts Say About UPV or XPP?
ProShares Ultra FTSE Europe has a consensus price target of --, signalling downside risk potential of --. On the other hand ProShares Ultra FTSE China 50 has an analysts' consensus of -- which suggests that it could fall by --. Given that ProShares Ultra FTSE Europe has higher upside potential than ProShares Ultra FTSE China 50, analysts believe ProShares Ultra FTSE Europe is more attractive than ProShares Ultra FTSE China 50.
Company Buy Ratings Hold Ratings Sell Ratings UPVProShares Ultra FTSE Europe0 0 0 XPPProShares Ultra FTSE China 500 0 0 -
Is UPV or XPP More Risky?
ProShares Ultra FTSE Europe has a beta of 1.865, which suggesting that the stock is 86.534% more volatile than S&P 500. In comparison ProShares Ultra FTSE China 50 has a beta of 0.642, suggesting its less volatile than the S&P 500 by 35.778%.
-
Which is a Better Dividend Stock UPV or XPP?
ProShares Ultra FTSE Europe has a quarterly dividend of $0.34 per share corresponding to a yield of 1.8%. ProShares Ultra FTSE China 50 offers a yield of 2.76% to investors and pays a quarterly dividend of $0.16 per share. ProShares Ultra FTSE Europe pays -- of its earnings as a dividend. ProShares Ultra FTSE China 50 pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios UPV or XPP?
ProShares Ultra FTSE Europe quarterly revenues are --, which are smaller than ProShares Ultra FTSE China 50 quarterly revenues of --. ProShares Ultra FTSE Europe's net income of -- is lower than ProShares Ultra FTSE China 50's net income of --. Notably, ProShares Ultra FTSE Europe's price-to-earnings ratio is -- while ProShares Ultra FTSE China 50's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for ProShares Ultra FTSE Europe is -- versus -- for ProShares Ultra FTSE China 50. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income UPVProShares Ultra FTSE Europe-- -- -- -- XPPProShares Ultra FTSE China 50-- -- -- --
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
How High Will Brown Forman Stock Go?
On the surface, Brown‑Forman (NYSE: BF.B) is having an unremarkable year.…
Is Bloom Energy Flying Under the Radar?
Bloom Energy (NYSE:BE) manufactures scalable fuel cells for providing on-site…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 59x
Buy
61
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
42
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Alerts
Buy
55
TLN alert for Jul 19
Talen Energy [TLN] is up 24.44% over the past day.
Sell
48
CRSP alert for Jul 19
CRISPR Therapeutics AG [CRSP] is up 18.22% over the past day.
Buy
83
SOC alert for Jul 19
Sable Offshore [SOC] is up 11.86% over the past day.
